نتائج البحث - Sachdev, Pallavi
- يعرض 1 - 11 نتائج من 11
-
1
-
2
-
3
Vav3 Mediates Receptor Protein Tyrosine Kinase Signaling, Regulates GTPase Activity, Modulates Cell Morphology, and Induces Cell Transformation حسب Zeng, Liyu, Sachdev, Pallavi, Yan, Lunbiao, Chan, Joseph L., Trenkle, Thomas, McClelland, Michael, Welsh, John, Wang, Lu-Hai
منشور في 2000نص -
4
G protein βγ subunit interaction with the dynein light-chain component Tctex-1 regulates neurite outgrowth حسب Sachdev, Pallavi, Menon, Santosh, Kastner, David B, Chuang, Jen-Zen, Yeh, Ting-Yu, Conde, Cecilia, Caceres, Alfredo, Sung, Ching-Hwa, Sakmar, Thomas P
منشور في 2007نص -
5
Correlative serum biomarker analyses in the phase 2 trial of lenvatinib-plus-everolimus in patients with metastatic renal cell carcinoma حسب Lee, Chung-Han, Motzer, Robert J., Glen, Hilary, Michaelson, M. D., Larkin, James, Minoshima, Yukinori, Kanekiyo, Michio, Ikezawa, Hiroki, Sachdev, Pallavi, Dutcus, Corina E., Funahashi, Yasuhiro, Voss, Martin H.
منشور في 2020نص -
6
First-in-human study of the PARP/tankyrase inhibitor E7449 in patients with advanced solid tumours and evaluation of a novel drug-response predictor حسب Plummer, Ruth, Dua, Divyanshu, Cresti, Nicola, Drew, Yvette, Stephens, Peter, Foegh, Marie, Knudsen, Steen, Sachdev, Pallavi, Mistry, Bipin M., Dixit, Vaishali, McGonigle, Sharon, Hall, Nancy, Matijevic, Mark, McGrath, Shannon, Sarker, Debashis
منشور في 2020نص -
7
Discovery of a CXCR4 agonist pepducin that mobilizes bone marrow hematopoietic cells حسب Tchernychev, Boris, Ren, Yong, Sachdev, Pallavi, Janz, Jay M., Haggis, Lynn, O'Shea, Adam, McBride, Ed, Looby, Richard, Deng, Qing, McMurry, Thomas, Kazmi, Manija A., Sakmar, Thomas P., Hunt, Stephen, Carlson, Kenneth E.
منشور في 2010نص -
8
Phase I dose-escalation study of the multikinase inhibitor lenvatinib in patients with advanced solid tumors and in an expanded cohort of patients with melanoma حسب Hong, David S., Kurzrock, Razelle, Wheler, Jennifer J., Naing, Aung, Falchook, Gerald S., Fu, Siqing, Kim, Kevin B., Davies, Michael A., Nguyen, Ly M., George, Goldy C., Xu, Lucy, Shumaker, Robert, Ren, Min, Mink, Jennifer, Bedell, Cynthia, Andresen, Corina, Sachdev, Pallavi, O'Brien, James P., Nemunaitis, John
منشور في 2015نص -
9
Lenvatinib Plus Pembrolizumab in Patients With Advanced Endometrial Cancer حسب Makker, Vicky, Taylor, Matthew H., Aghajanian, Carol, Oaknin, Ana, Mier, James, Cohn, Allen L., Romeo, Margarita, Bratos, Raquel, Brose, Marcia S., DiSimone, Christopher, Messing, Mark, Stepan, Daniel E., Dutcus, Corina E., Wu, Jane, Schmidt, Emmett V., Orlowski, Robert, Sachdev, Pallavi, Shumaker, Robert, Casado Herraez, Antonio
منشور في 2020نص -
10
First-in-human phase I study of immunomodulatory E7046, an antagonist of PGE(2)-receptor E-type 4 (EP4), in patients with advanced cancers حسب Hong, David S, Parikh, Aparna, Shapiro, Geoffrey I, Varga, Andrea, Naing, Aung, Meric-Bernstam, Funda, Ataman, Özlem, Reyderman, Larisa, Binder, Terri A, Ren, Min, Liu, Mingjie, Dayal, Satish, Siu, Amy Y, Sachdev, Pallavi, Xu, Lucy, Bhagawati-Prasad, Vijay, Tchakov, Ilian, Ooi, Chean Eng, Bao, Xingfeng, Marabelle, Aurelien
منشور في 2020نص -
11
High response rate and durability driven by HLA genetic diversity in kidney cancer patients treated with the immunotherapy combination lenvatinib and pembrolizumab. حسب Lee, Chung-Han, DiNatale, Renzo G., Chowell, Diego, Krishna, Chirag, Makarov, Vladimir, Valero, Cristina, Vuong, Lynda, Lee, Mark, Weiss, Kate, Hoen, Doug, Morris, Luc, Reznik, Ed, Murray, Samuel, Kotecha, Ritesh, Voss, Martin H., Carlo, Maria I, Feldman, Darren, Sachdev, Pallavi, Adachi, Yusuke, Minoshima, Yukinori, Matsui, Junji, Funahashi, Yasuhiro, Nomoto, Kenichi, Hakimi, A. Ari, Motzer, Robert J., Chan, Timothy A.
منشور في 2021نص